Literature DB >> 9925870

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.

H Verder1, P Albertsen, F Ebbesen, G Greisen, B Robertson, A Bertelsen, L Agertoft, B Djernes, E Nathan, J Reinholdt.   

Abstract

OBJECTIVE: To determine whether early versus late treatment with porcine surfactant (Curosurf) reduces the requirement of mechanical ventilation in very preterm infants primarily supported by nasal continuous positive airway pressure (nasal CPAP).
DESIGN: Multicenter randomized, controlled trial. PATIENTS: The study population comprised 60 infants <30 weeks' gestation with respiratory distress syndrome (RDS) who had an arterial to alveolar oxygen tension ratio (a/APO2) of 0.35 to 0.22. The cohort from which the study population was generated comprised 397 infants.
RESULTS: The need for mechanical ventilation or death within 7 days of age was reduced from 63% in the late-treated infants to 21% in early-treated infants. Increasing numbers of antenatal steroid doses also improved the outcome, especially in the early-treated infants. Six hours after randomization mean a/APO2 rose to 0.48 in the early-treated infants compared with 0.36 in the late-treated. The need of mechanical ventilation before discharge was reduced from 68% in the late-treated to 25% in the early-treated infants.
CONCLUSIONS: Nasal CPAP in combination with early treatment with Curosurf significantly improves oxygenation and reduces the subsequent need for mechanical ventilation in infants <30 weeks' gestational age with RDS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925870     DOI: 10.1542/peds.103.2.e24

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  57 in total

Review 1.  Changing trends in the management of respiratory distress syndrome (RDS).

Authors:  Praveen Kumar; P S Sandesh Kiran
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

2.  To intubate or not--that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants.

Authors:  N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

3.  Outcome of very low birthweight infants after introducing a new standard regime with the early use of nasal CPAP.

Authors:  Ruth-Maria Miksch; Sven Armbrust; Jens Pahnke; Christoph Fusch
Journal:  Eur J Pediatr       Date:  2008-01-03       Impact factor: 3.183

4.  Outcome of intubate surfactant rapidly extubate (InSuRE): an Indian experience.

Authors:  Amit Tagare; Sandeep Kadam; Umesh Vaidya; Anand Pandit
Journal:  Indian J Pediatr       Date:  2013-06-18       Impact factor: 1.967

5.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-02       Impact factor: 2.253

6.  Recommendations for neonatal surfactant therapy.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-02       Impact factor: 2.253

7.  Safety and effectiveness of bubble continuous positive airway pressure in preterm neonates with respiratory distress.

Authors:  S S Mathai; A Rajeev; K M Adhikari
Journal:  Med J Armed Forces India       Date:  2014-09-26

Review 8.  Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.

Authors:  H J Niemarkt; M C Hütten; Boris W Kramer
Journal:  Neonatology       Date:  2017-05-25       Impact factor: 4.035

9.  Comparison of the Pharmacoeconomics of Calfactant and Poractant Alfa in Surfactant Replacement erapy.

Authors:  Michael M Zayek; Fabien G Eyal; Robert C Smith
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

Review 10.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.